1Heick A, Striver E. Chlamydia pneumoniae-associated ADEM [J]. Eur J Neurol, 2000, 7(4):435-438.
2Hammerschlag MR. Chlamydia pneumoniae and the lung [J]. Eur Respir J, 2000 , 16(5):1001-1007.
3Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: Serological results of a prospective, population-based study in primary health care[J]. Respirology, 2004, 9 (1):109-14.
4Wattanathum A, Boonyongsunchai P, Palwatwichai A, et al. Chlamydia pneumoniae in community-acquired pneumonia[J]. J Med Assoc Thai, 2001 , 84(1):69-74.
5Wu JS, Lin JC, Chang FY. Chlamydia pneumoniae infection in community-acquired pneumonia in Taiwan[J]. J Microbiol Immunol Infect, 2000 , 33(1):34-38.
6Blasi F,Tarsia P, Arosio C, et al. Epidemiology of Chlamydia pneumoniae [J]. Clin Microbiol Infect, 1998 , 4 (suppl 4):s1-s6.
7Grayston JT, Aldous MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis [J]. J Infect Dis, 1993, 168(5): 1231-1235.
8Luna M ,Angela F,Ruben A. Community acquired pneumonia. etiology, epidemiology, and outcome at a teaching hospital in Argentina [J]. Chest, 2000 ,118 (5):1344-1354.
2Heick A, Striver E. Chlamydia pneumoniae-associated ADEM [J].Eur J Neurol, 2000, 7( 4) : 435- 438.
3Legan M, Vraspir-Porenta O, Kese D, et al. Pathohistological changes in diffuse coronary atherosclerosis and chronic infection caused by Chlamydia pneumoniae [J].Bosn J Basic Sci,2004,4(1):19-22.
4Paldanius M,Bloigu A,Alho M,et a1.Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland [J].Clin Diagn Lab Im munol,2005,12(5):654-659.
5Martinez TM, Kogan R, Rojas P, et al. Diagonosis of Chlamydia pneumonia in communit y-acuquired pneumonia in children in Chile [J] . Act a Paediat r, 2000, 89 ( 6) : 650-653.
